Nautilus Biotechnology (NAUT) Profit After Tax (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Profit After Tax data on file, last reported at -$14.7 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 11.53% year-over-year to -$14.7 million; the trailing twelve-month figure through Mar 2026 stood at -$57.1 million (up 16.86% YoY), and the FY2025 full-year result was -$59.0 million, up 16.64% from the prior year.
• Profit After Tax eased to -$14.7 million in Q1 2026, from -$13.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$13.4 million in Q4 2022 to a low of -$18.7 million in Q1 2024.
• A 5-year average of -$15.7 million and a median of -$15.8 million in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax plunged 87.45% in 2022 and gained 21.67% in 2025, its largest moves.
• Tracing NAUT's Profit After Tax over 5 years: stood at -$13.4 million in 2022, then declined by 26.96% to -$17.0 million in 2023, then decreased by 3.35% to -$17.6 million in 2024, then increased by 21.67% to -$13.8 million in 2025, then retreated by 6.65% to -$14.7 million in 2026.
• Business Quant data shows NAUT's Profit After Tax at -$14.7 million in Q1 2026, -$13.8 million in Q4 2025, and -$13.6 million in Q3 2025.